Visit the COVID-19 and HIV page for the latest updates on the novel coronavirus outbreak and HIV.
Ending the HIV Epidemic in the U.S. Progress
The Ending the HIV Epidemic in the U.S. (EHE) initiative uses six HIV data indicators to measure progress toward national 2025 and 2030 HIV prevention goals. While the United States has made modest progress toward these goals in recent years, the nation is not on pace to reach them. An increase in dedicated resources would be needed to fully scale up EHE strategies, so that they can reach all the people who need them.
Goals
Defined as the estimated number of new HIV infections in a given year. In 2021, there were an estimated 32,100 new HIV infections.
Overarching goal: Reduce new HIV infections in the United States by 75% by 2025 and by 90% by 2030
Defined as the estimated percentage of people with HIV who have received an HIV diagnosis. In 2021, 87% of people with HIV had received a diagnosis.
Midterm goal: Increase knowledge of HIV status to 95% by 2025
National Indicators
Progress on the indicators below will have the greatest impact on ending the HIV epidemic in the United States by 2030.
Defined as the number of people who receive an HIV diagnosis in a given year that is confirmed by laboratory or clinical evidence. In 2021, data showed 36,189 people received an HIV diagnosis.
Goal: Decrease the yearly number of new HIV diagnoses by 75% by 2025 and 90% by 2030
Defined as the estimated percentage of people with HIV who have received an HIV diagnosis. In 2021, 87% of people with HIV had received a diagnosis.
Midterm goal: Increase knowledge of HIV status to 95% by 2025
Defined as the percentage of people with diagnosed HIV in a given year who have an amount of HIV that is less than 200 copies per milliliter of blood. In 2021, data showed 66% of people with diagnosed HIV were virally suppressed.
Goal: Increase the percentage of people with diagnosed HIV who are virally suppressed to 95% by 2025
Defined as the estimated percentage of individuals with indications for PrEP classified as having been prescribed PrEP. In 2021, data showed 30% of people who could benefit from PrEP were prescribed it.
Goal: Increase PrEP coverage to 50% by 2025
America’s HIV Epidemic Analysis Dashboard (AHEAD) supports EHE by tracking data on these indicators. CDC’s National HIV Surveillance System provides the data for five of the six core indicators. Learn more about the indicators and explore the data.
Go to AHEAD